Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Guelph

$26,000.00

Enzymology of xenobiotic metabolism

FY 2015-16

Summary
Foreign chemicals, such as pollutants, drugs, and other toxicants, are metabolized (i.e., chemically modified, prior to elimination) in the human body. This process of metabolism, catalyzed by enzymes in the liver and other organs, is the main determinant of the rate at which a drug is eliminated from the body; this, in turn, influences the effectiveness and toxicity of the drug. . Rates of drug metabolism vary widely among individuals, and genetic factors are an important source of this variation, which can have major effects on response to drug therapy. When treated with standard doses, ""poor metabolizers"" may be at risk of overdose toxicity while ""ultrarapid metabolizers"" fail to receive therapeutic benefit. With some drugs, metabolism may generate an active agent, and so the opposite scenario applies: ultrarapid metabolizers risk overdose. The completion of the human genome and subsequent spectacular improvements in DNA sequencing technology have recently provided deep new insight into genetic variations in the enzymes of drug metabolism. Also, genomic analysis has revealed the existence of previously unknown genes and enzymes. The focus of research in the Josephy lab is the analysis of the functional effects of human genetic variation in drug and toxicant metabolism enzymes, including the glutathione transferase and cytochrome P450 families of enzymes.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
2537-2012
Name nom
Josephy, David
Department département
Molecular and Cellular Biology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2012
Award amount
26000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
5404
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Enzymes
Research subject fr
Enzymes
Partie
4
Nb partie
5
Application title
Enzymology of xenobiotic metabolism
Keyword
NSERC
Application summary
Foreign chemicals, such as pollutants, drugs, and other toxicants, are metabolized (i.e., chemically modified, prior to elimination) in the human body. This process of metabolism, catalyzed by enzymes in the liver and other organs, is the main determinant of the rate at which a drug is eliminated from the body; this, in turn, influences the effectiveness and toxicity of the drug. . Rates of drug metabolism vary widely among individuals, and genetic factors are an important source of this variation, which can have major effects on response to drug therapy. When treated with standard doses, ""poor metabolizers"" may be at risk of overdose toxicity while ""ultrarapid metabolizers"" fail to receive therapeutic benefit. With some drugs, metabolism may generate an active agent, and so the opposite scenario applies: ultrarapid metabolizers risk overdose. The completion of the human genome and subsequent spectacular improvements in DNA sequencing technology have recently provided deep new insight into genetic variations in the enzymes of drug metabolism. Also, genomic analysis has revealed the existence of previously unknown genes and enzymes. The focus of research in the Josephy lab is the analysis of the functional effects of human genetic variation in drug and toxicant metabolism enzymes, including the glutathione transferase and cytochrome P450 families of enzymes.